Session Objectives

Learn from the research that is redefining cardiovascular health and discover how to put it into practice in your own setting.

PCNA_0250

Pharmacology Preconference

Innovations in Hypertension Management

  1. Appraise the most recent hypertension guidelines and their implications for clinical practice.
  2. Analyze emerging innovations in hypertension treatment, including renal denervation and aldosterone synthase inhibitors.
  3. Evaluate the role of team‑based care and Certified Hypertension Centers in improving hypertension control and treatment adherence.
  4. Apply current hypertension guidelines and emerging evidenced based therapies to nursing practice for optimized cardiovascular care.

New Dyslipidemia Management in 2027

  1. Interpret the key updates in the latest dyslipidemia guidelines and their implications for patient care.
  2. Apply evidence-based pharmacologic interventions to optimize lipid management and reduce cardiovascular risk.
  3. Identify the role of lipoprotein(a) [Lp(a)] in cardiovascular risk assessment and its impact on clinical decision-making.
  4. Summarize emerging clinical trials that may influence future dyslipidemia prevention and management.

Obesity as a Precursor to Cardiometabolic Syndrome: Treatment and Prevention Strategies

  1. Explain the pathophysiological link between obesity and the development of cardiometabolic syndrome.
  2. Compare the pharmacologic options for obesity management, including their mechanisms of action, efficacy, and cardiovascular benefits.
  3. Apply evidence-based pharmacotherapy guidelines to individualize obesity treatment and mitigate cardiometabolic risks.
  4. Integrate pharmacologic interventions for obesity into comprehensive cardiovascular risk reduction strategies.

Pharmacologic Management Across the Four Stages of Heart Failure

  1. Apply evidence-based pharmacologic therapies for Stage A patients to prevent the onset of heart failure (including management of hypertension, diabetes, and atherosclerosis).
  2. Integrate guideline-directed medical therapies) for Stage B patients (focusing on ACE inhibitors, ARBs, beta-blockers, and SGLT2 inhibitors to halt disease progression).
  3. Optimize pharmacologic regimens for Stage C heart failure (including the use of MRAs, diuretics, and newer agents like vericiguat).
  4. Evaluate advanced pharmacologic and device-based therapies for Stage D heart failure (such as inotropes, vasopressin antagonists, and palliative care strategies).

General Sessions

Women’s Heart Health Across the Lifespan: Navigating Menopause, Hormone Therapy, and Cardiovascular Risk

  1. Analyze sex specific cardiovascular risk trajectories across the lifespan, with emphasis on the menopausal transition and its physiologic impact on vascular health.
  2. Evaluate current evidence on hormone therapy, including indications, risks, and timing, to determine its role in cardiovascular prevention for midlife and older women.
  3. Apply guideline based strategies for assessing and managing cardiometabolic risk in women experiencing perimenopause, menopause, or early surgical menopause.
  4. Integrate lifestyle interventions, shared decision making, and individualized hormone therapy considerations into comprehensive cardiovascular prevention plans for diverse female populations with emphasis on the role of CV nurse.

Lifestyle as Medicine: Innovative Strategies for Obesity and Cardiometabolic Health in Cardiovascular Care

  1. Analyze the pathophysiologic links between obesity, cardiometabolic dysfunction, and cardiovascular disease to identify high risk patient profiles
  2. Identify nutrition (new dietary guidelines) and muscle preserving strategies for cardiovascular patients and patients receiving anti-obesity pharmacological treatments
  3. Integrate lifestyle as medicine strategies into team based cardiovascular care models to enhance patient engagement, adherence, and long term outcomes (including multi-disciplinary cardiometabolic health centers as a case study example)

Cardiac Rehabilitation 2027: Policy, Nursing Leadership, and Mental Health Integration in Modern Models of Care

  1. Evaluate recent updates in cardiac rehabilitation models of care—including home‑based, hybrid, and technology‑enabled programs and their effectiveness in improving functional capacity, adherence, and cardiovascular risk reduction.
  2. Analyze emerging federal and state policy changes shaping cardiac rehabilitation access, reimbursement, and delivery in 2027.
  3. Apply evidence based mental health integration strategies such as depression screening, behavioral counseling, and digital support tools to cardiac rehabilitation case scenarios.

Stroke Prevention in Adult Cardiac Surgery: Evidence‑Based Insights for Nursing Practice

  1. Describe the incidence, timing, and mechanisms of stroke in adult cardiac surgery.
  2. Identify key patient‑level and procedure‑related risk factors for stroke following cardiac surgery.
  3. Evaluate evidence‑based stroke prevention strategies and emerging technologies including AI-driven risk assessment and remote monitoring tools to minimize stroke before, during, and after cardiac surgery.

Precision Cardiology: Applying Pharmacogenomics for Risk Stratification and Guided Therapy

  1. Evaluate evidence supporting pharmacogenomic guided prescribing for antiplatelet agents, statins, antihypertensives, and heart failure therapies.
  2. Apply pharmacogenomic data to clinical case scenarios to optimize medication selection, dosing, and safety in cardiovascular care.
  3. Integrate pharmacogenomic testing into team based cardiovascular care pathways to enhance precision therapy, reduce adverse events, and improve treatment effectiveness

Structural Heart Disease: Navigating Patient Treatment Options and the Nurse’s Role in Shared Decision-Making

  1. Describe the spectrum of structural heart diseases with a focus on valve pathologies and their clinical implications for patient outcomes
  2. Compare and contrast catheter-based and surgical treatment options (e.g., TAVR, TMVR, surgical repair/replacement) for valve diseases and other structural heart conditions, including indications, risks, and benefits.
  3. Integrate nursing strategies and shared decision-making to engage patients and families in selecting optimal treatment plans based on individual values, preferences, and clinical evidence.

Atrial Fibrillation: Nursing Care Across the Continuum

  1. Describe the risks of atrial fibrillation and the continuum of nursing care and education required to manage patients across the disease trajectory
  2. Apply evidence-based nursing interventions for patients undergoing traditional and novel atrial fibrillation ablation (addressing pre-, peri-, and post-procedural stages)
  3. Analyze patient-centered medical management strategies, including rate/rhythm control, anticoagulation, and monitoring to optimize outcomes for patients with Afib.

Aortopathy Unveiled: SCAD, Dissections, and Nursing Strategies for Recognition and Response

  1. Identify the types, risk factors, and clinical manifestations of aortopathy, including SCAD and aortic dissections, to facilitate early recognition and intervention.
  2. Apply guideline directed nursing actions for emergent stabilization, hemodynamic monitoring, and interdisciplinary escalation in suspected SCAD or aortic dissection cases.
  3. Describe the nursing role in monitoring, patient education, and care coordination for patients with aortopathy, including long-term follow-up and psychological support.

Leading the Future: Cardiovascular Nurses at the Forefront

  1. Describe the leadership role of cardiovascular nurses in implementing innovation and technology to improve cardiovascular care.
  2. Identify opportunities to integrate emerging technologies into cardiovascular nursing workflows.
  3. Apply ethical principles to the use of AI and digital tools in nursing practice.
  4. Discuss strategies to mentor and develop future cardiovascular nurse leaders through collaboration and professional development.

Breakout Sessions

Hemodynamics Made Easy: A Hands-On Workshop for Interpretation, Remote Monitoring, and Device Therapy

  1. Analyze core hemodynamic parameters—including preload, afterload, contractility, and cardiac output—to identify patterns associated with common cardiovascular conditions.
  2. Interpret invasive and non invasive hemodynamic tracings (e.g., arterial lines, PA catheters, implantable sensors) to guide clinical decision making in acute and ambulatory care for heart failure patients and beyond.
  3. Integrate hemodynamic assessment, remote monitoring technologies, and device based therapies into team based cardiovascular care pathways to improve functional status and reduce hospitalizations.

AI Simulation Workshop: Obesity and Cardiometabolic Health in Cardiovascular Care

  1. Explain how cardiovascular, kidney, and metabolic diseases interconnect and amplify risk
  2. Identify evidence-based nutrition recommendations and muscle-preserving strategies for patients with cardiovascular disease, including those receiving anti-obesity pharmacotherapy.
  3. Apply motivational interviewing and behavior-change techniques to support sustainable lifestyle change in nutrition and activity through conversational AI simulation.

From Evidence to Impact: Professional Development in CVD Prevention and Control

  1. Review programs and tools for quality improvement and evidence-based practice (EBP) projects to bridge the gap between research and clinical practice in CVD prevention.
  2. Apply evidence based prevention frameworks to real world case scenarios to strengthen skills in risk assessment, communication, and patient engagement (including technology and data driven tools).
  3. Integrate professional development tools, quality improvement methods, and evidence based interventions to design impactful CVD prevention initiatives within diverse care settings (including system level).